David Erlinge
391 – 400 of 473
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors
(
- Contribution to journal › Published meeting abstract
-
Mark
Pharmacological characterization of the P2Y11 Thr-87 variant
(
- Contribution to journal › Published meeting abstract
-
Mark
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease
(
- Contribution to journal › Article
-
Mark
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature
(
- Contribution to journal › Published meeting abstract
-
Mark
Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1.
(
- Contribution to journal › Article
-
Mark
P2 receptors in cardiovascular regulation and disease.
(
- Contribution to journal › Article
-
Mark
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo.
(
- Contribution to journal › Article
-
Mark
The P2Y(13) Met-158-Thr Polymorphism, Which Is in Linkage Disequilibrium with the P2Y(12) Locus, Is Not Associated with Acute Myocardial Infarction.
(
- Contribution to journal › Article
-
Mark
Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y(6) receptors.
(
- Contribution to journal › Article